Test

Test

(Shutterstock)

Key Takeaways

  • bullet one

Fresenius Kabi has launched its denosumab biosimilars Bomyntra and Conexxence in Canada, joining an increasingly crowded market.

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Interviews

  • Test

    Test

  • ADHD

    This is regarding ADHD.

  • test

More from Leadership

  • Wagner Adds Germany To Role As Stada Simplifies Structure

    Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

  • ADHD

    This is regarding ADHD.

  • test